PTPN1 and type 2 diabetes mellitus: Sodium tungstate has been proposed as a potential therapeutic agent for type 2 diabetes and although its effects as an inhibitor of PTP1B have been acknowledged, the antidiabetic properties of sodium tungstate may be related to effects other than that of being a PTP1B inhibitor [98].